Skip to main content
Marc Pfeffer, MD, Cardiology, Boston, MA, Brigham and Women's Hospital

MarcAPfefferMD

Cardiology Boston, MA

Adult Congenital Heart Disease, Heart Failure & Transplantation

Victor J. Dzau Professor of Medicine, Brigham and Women's Hospital

Dr. Pfeffer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Pfeffer's full profile

Already have an account?

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1979 - 1980
  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Internal Medicine, 1976 - 1979
  • University of Oklahoma College of Medicine
    University of Oklahoma College of MedicineClass of 1976

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1980 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2006-2014
  • Boston Magazine Castle Connolly, 2008-2013
  • Fellow (FACC) American College of Cardiology
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction  
    Amil M Shah, Nancy K Sweitzer, Akshay S Desai, James C Fang, Sanjeev Saksena, Bertram Pitt, Sanjiv J Shah, Marc A Pfeffer, Scott D Solomon, ScienceDirect

Lectures

  • Progression from Hypertension to Heart Failure: Mechanisms, Epidemiology, and Prevention 
    55th Annual Scientific Session & Expo, Atlanta, Georgia, USA
  • Progression from Hypertension to Heart Failure: Mechanisms, Epidemiology, and Prevention 
    American College of Cardiology, 55th Annual Scientific Session & Expo, Atlanta, Georgia, USA
  • TOPCAT: Effects of Spironolactone on CV Outcomes in Patients With Heart Failure With Preserved Ejection Fraction 
    American Heart Association, Scientific Sessions 2013, Dallas, Texas, USA
  • Join now to see all

Other

Authored Content

  • Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
  • Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
  • Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial CohortJune 2017
  • 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
  • Join now to see all

Press Mentions

  • PARADISE-MI: Sacubitril-Valsartan Fails to Outperform ACE Inhibitor After MI
    PARADISE-MI: Sacubitril-Valsartan Fails to Outperform ACE Inhibitor After MINovember 11th, 2021
  • ACC.21: Late-Breaking Science Brings Practice-Changing Insights
    ACC.21: Late-Breaking Science Brings Practice-Changing InsightsJune 17th, 2021
  • Cover Story | ACC.21: Reuniting the Cardiovascular Community; Reimagining Global Heart Health
    Cover Story | ACC.21: Reuniting the Cardiovascular Community; Reimagining Global Heart HealthJune 17th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations